R-S-R

CAS No. 115035-42-2

R-S-R( ——— )

Catalog No. M41799 CAS No. 115035-42-2

H-Arg-Ser-Arg-OH is a short peptide. H-Arg-Ser-Arg-OH is a motif of di-leucine and RSRR, it can be used to design larger peptides and compound.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    R-S-R
  • Note
    Research use only, not for human use.
  • Brief Description
    H-Arg-Ser-Arg-OH is a short peptide. H-Arg-Ser-Arg-OH is a motif of di-leucine and RSRR, it can be used to design larger peptides and compound.
  • Description
    H-Arg-Ser-Arg-OH is a short peptide. H-Arg-Ser-Arg-OH is a motif of di-leucine and RSRR, it can be used to design larger peptides and compound.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    115035-42-2
  • Formula Weight
    417.5
  • Molecular Formula
    C15H31N9O5
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Restituito S, et al. Multiple motifs regulate the trafficking of GABA(B) receptors at distinct checkpoints within the secretory pathway. Mol Cell Neurosci. 2005 Apr;28(4):747-56.?
molnova catalog
related products
  • Revdofilimab

    Revdofilimab (ABBV-368) is a human IgG1 monoclonal antibody that acts as an agonist against OX40, a TNF receptor superfamily member expressed on activated and memory T cell subsets as well as T regulatory cells .

  • 19-Oxocinobufagin

    19-Oxocinobufagin is a natural product from Bufo bufo gargarizans Cantor.

  • SSAA09E3

    SSAA09E3 is a novel inhibitor of SARS-CoV replication, acting by preventing fusion of the viral membrane with the host cellular membrane.